Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)

• Status: Completed
• Trial end date: 2012-01-01

Summary

The objective is to describe the time to recovery of symptoms (cough, mucus, fever, sore throat, and others), tolerability and compliance of treatment with clarithromycin once daily in patients with upper or lower respiratory tract infections in the routine clinical practice.

Details

• Lead Sponsor: Abbott
• Collaborators: Eilaf; Eilaf CRO
• Treatments: Clarithromycin